170 related articles for article (PubMed ID: 12535291)
1. Treating interdialytic hyperkalemia with fludrocortisone.
Imbriano LJ; Durham JH; Maesaka JK
Semin Dial; 2003; 16(1):5-7. PubMed ID: 12535291
[TBL] [Abstract][Full Text] [Related]
2. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.
Kim DM; Chung JH; Yoon SH; Kim HL
Nephrol Dial Transplant; 2007 Nov; 22(11):3273-6. PubMed ID: 17616536
[TBL] [Abstract][Full Text] [Related]
3. Fludrocortisone for the treatment of heparin-induced hyperkalemia.
Sherman DS; Kass CL; Fish DN
Ann Pharmacother; 2000 May; 34(5):606-10. PubMed ID: 10852087
[TBL] [Abstract][Full Text] [Related]
4. Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis.
Furuya R; Kumagai H; Sakao T; Maruyama Y; Hishida A
Nephron; 2002; 92(3):576-81. PubMed ID: 12372940
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
[TBL] [Abstract][Full Text] [Related]
6. Exogenous mineralocorticoid hormone improves predialysis hyperkalemia in anephric man.
Whalen JE; Cohen LH
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():1-4. PubMed ID: 756027
[No Abstract] [Full Text] [Related]
7. Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease.
Singhal PC; Desroches L; Mattana J; Abramovici M; Wagner JD; Maesaka JK
Am J Nephrol; 1993; 13(2):138-41. PubMed ID: 8342580
[TBL] [Abstract][Full Text] [Related]
8. Hyperkalaemia in a patient with Graves' disease.
Ng CW; Chan NN; So WY; Chan WB; Chow CC
Int J Clin Pract; 2003 Sep; 57(7):631-2. PubMed ID: 14529068
[TBL] [Abstract][Full Text] [Related]
9. Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation.
Jones JW; Gruessner RW; Gores PF; Matas AJ
Transplantation; 1993 Oct; 56(4):1013-5. PubMed ID: 8212180
[No Abstract] [Full Text] [Related]
10. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
Pelleya R; Oster JR; Perez GO
Am J Nephrol; 1983; 3(4):223-7. PubMed ID: 6351617
[TBL] [Abstract][Full Text] [Related]
11. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
Dreyling KW; Wanner C; Schollmeyer P
Clin Nephrol; 1990 Apr; 33(4):179-83. PubMed ID: 2350905
[TBL] [Abstract][Full Text] [Related]
12. Current and future potassium binders.
Bakris GL
Nephrol News Issues; 2016 Apr; 30(4):suppl 27-31. PubMed ID: 27254903
[No Abstract] [Full Text] [Related]
13. Potassium balance in dialysis patients.
Sanghavi S; Whiting S; Uribarri J
Semin Dial; 2013; 26(5):597-603. PubMed ID: 24073843
[TBL] [Abstract][Full Text] [Related]
14. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Schweiger B; Moriarty MW; Cadnapaphornchai MA
Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
Sekihara H
Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
Schambelan M; Sebastian A; Rector FC
Kidney Int; 1981 May; 19(5):716-27. PubMed ID: 7026872
[TBL] [Abstract][Full Text] [Related]
18. Severe symptomatic hyperkalemia in an adrenalectomized woman due to enhanced mineralocorticoid requirement.
Daughaday WH; Rendleman D
Ann Intern Med; 1967 Jun; 66(6):1197-203. PubMed ID: 6027948
[No Abstract] [Full Text] [Related]
19. Selective aldosterone deficiency in chronic pyelonephritis.
Vagnucci AH
Nephron; 1970; 7(6):524-37. PubMed ID: 5495285
[No Abstract] [Full Text] [Related]
20. Hyperkalemia across the Continuum of Kidney Function.
Palmer BF; Clegg DJ
Clin J Am Soc Nephrol; 2018 Jan; 13(1):155-157. PubMed ID: 29114006
[No Abstract] [Full Text] [Related]
[Next] [New Search]
